Guangdong Procapzoom Biosciences Co., Ltd.

This early-phase trial tests a new treatment for people with refractory myasthenia gravis, a condition causing severe muscle weakness. The treatment uses donor immune cells (CAR-NK cells) engineered to target and calm the immune system's attack on muscles. Fifteen participants wi…

This early-stage trial will test the safety and tolerability of a new drug called SZ1003 in 12 adults with advanced hepatocellular carcinoma who have already tried and failed at least two standard treatments. Participants receive the drug by infusion every two weeks, and research…

This early study tests a special contact lens (MSCohi-O) for people with Sjögren's syndrome whose dry eyes don't improve with standard treatments. Twelve participants will wear the lenses for 12 hours a day over 14 sessions. Researchers will check for side effects and measure cha…

This early trial tests whether exosome eye drops can safely relieve dry eye symptoms in people with Sjögren's syndrome. Twelve adults whose dry eyes haven't improved with standard treatments will use the drops four times daily for two weeks. The main goal is to check for side eff…